South Korea Prepares for Continued COVID-19 Pandemic as Herd Immunity Looms

Strategic Insights -

As South Korea inches closer to achieving herd immunity by November, the government is preparing for the ongoing pandemic by securing additional vaccine supplies for next year. With over 10 million people already vaccinated, the country aims to reach 14 million by the end of the month, using vaccines from five pharmaceutical firms: AstraZeneca, Pfizer, Johnson & Johnson's Janssen, Moderna, and Novavax. Despite making progress, experts predict the COVID-19 outbreak will continue for some time, with variants expected to proliferate.

Key Takeaways:

  • South Korea aims to secure additional vaccine supplies for next year, considering the ongoing pandemic and potential need for booster shots.
  • The country has already vaccinated over 10 million people, using vaccines from five pharmaceutical firms, and aims to reach 14 million by the end of the month.
  • The government is preparing to consider various factors, including safety and efficacy, when deciding on booster shots or vaccine updates.
  • Health experts predict the COVID-19 outbreak will continue for some time, with numerous variants expected to proliferate.
  • South Korea is supporting the development of homegrown vaccines to secure vaccine sovereignty.
  • The country has reported an increase of 611 new COVID-19 cases, bringing the total caseload to 146,303.

Statistics:

  • Over 10 million people in South Korea have received their first vaccine shots.
  • The country aims to reach 14 million vaccinated by the end of the month.
  • The total COVID-19 caseload in South Korea reached 146,303 as of Thursday.
  • The country reported 611 new COVID-19 cases on Thursday, marking the second consecutive day with over 600 cases.

Sources:

  • Yonhap News Agency